@FiercePharma: Not as good for branded pharma, CHMP also OK'd generic versions of Forest's Namenda + Boehringer's Micardis. More | Follow @FiercePharma
@AlisonBFierce: Roche said U.S. regulators will allow it to begin selling the company's reserve stock of adult Tamiflu capsules. News | Follow @AlisonBFierce
@EricPFierce: Costco jumps into pharmacy benefits, bringing a new player to the table for drug companies to think about. Report | Follow @EricPFierce
> NuPathe ($PATH) has gotten FDA approval for a new patch that treats migraine headache pain by delivering sumatriptan, the most widely prescribed migraine medication. Story
> The European Union has suspended its approval of Merck's ($MRK) cholesterol drug Tredaptive after its failure in a major study raised safety concerns although the company has already started pulling it from the market there. Story
> The FDA says there are intermittent shortages of the liquid Tamiflu while capsules are available in 45 mg, 75 mg and 30 mg doses as is Relenza (zanamivir) Inhalation Powder. More
> Indian generics maker Aurobindo Pharma says it has gotten FDA approval to market a copycat of AstraZeneca's ($AZN) blood pressure drug Plendil Extended-release tablets. Item
> India is looking to export $15.5 billion worth of drugs this year, which would be a 17% increase, the Ministry of Commerce and Industry says. Item
Biotech News
@FierceBiotech: NuPathe jumps on FDA's OK for migraine drug. News | Follow @FierceBiotech
@JohnCFierce: VC ends '12 on a high note, outlook ranges from tough to terrific. More | Follow @JohnCFierce
@RyanMFierce: Does anyone know how much total funding (VC, corp., foundation) went into biotech? Still, $800M off in 2012 from '11 on the VC front. Yikes. | Follow @RyanMFierce
> Beer molecule discovery bolsters Seattle biotech upstart. Report
> Pfizer, Novartis win EU nods for new leukemia, eye drugs. Article
> Santhera Pharma slammed with EU denial of orphan drug. Story
@FierceMedDev: Medical device VC cash plunged 13% in 2012. Report | Follow @FierceMedDev
@DamianFierce: So, is $LIFE looking to sell itself? This PR is ominous. Release | Follow @DamianFierce
> Trauson's shares jump 41% on news of Stryker's $764M offer. Item
> GI Dynamics launches trial targeting FDA approval. Story
> FDA wants feedback on tighter hip-implant regs. News
And Finally... Teva Pharmaceutical Laboratories ($TEVA) has signed on Olympic speed skating medal winner Apolo Anton Ohno to promote is asthma inhaler ProAir HFA. Item